1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
2,76,44,231 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 1,094.90 | 970.58 | 911.63 |
| Total Income | 1,035.96 | 908.59 | 803.28 |
| Profit After Tax | 25.15 | -7.35 | 11.93 |
| EBITDA | 110.77 | 110.05 | 110.77 |
| NET Worth | 545.23 | 526.30 | 539.21 |
| Reserves and Surplus | 580.71 | 556.57 | 563.35 |
| Total Borrowing | 224.96 | 175.27 | 132.18 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Gujarat Kidney & Super Speciality Ltd. | Mainboard | ₹250.80 Cr | ₹114 | 61.62 | ₹104.54 | -8.30% | ₹128.20 (+0.79%) |
| Park Medi World Ltd. | Mainboard | ₹920.00 Cr | ₹162 | 29.21 | ₹147.95 | -8.67% | ₹280.25 (-1.50%) |
| Hannah Joseph Hospital Ltd. | SME | ₹42.00 Cr | ₹70 | 16.21 | ₹68.25 | -2.50% | ₹109.95 (+1.81%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | The company will not receive any proceeds from the Offer. |
About Sahajanand Medical Technologies IPO
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company focused on Class III and Class C/D devices, primarily in the fields of vascular and structural heart intervention. The company was the first globally to receive CE certification for a drug-eluting stent (DES) with a biodegradable polymer—Infinnium. The product portfolio spans three key categories: Vascular Intervention (VI): Includes coronary stents and balloons for minimally invasive blood vessel treatments. Structural Heart (SH): Covers advanced technologies such as Transcatheter Aortic Valve Implantation (TAVI) and Occluders. Other Products: Includes renal stents, peripheral Drug-Coated Balloons (DCBs), and selected trading products. Sahajanand operates two R&D centers—one in India and one in Thailand—supported by a team of 102 professionals, including biomedical engineers and clinical research specialists. The company has built a robust intellectual property base, with 102 patents granted globally and 71 pending patent applications, along with five design registrations in India. Key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 7
Contact Details
Sahajanand Medical Technologies Ltd. AddressSahajanand Estate, Wakharia Wadi,NR. Dabholi Char RastaNani Ved, Ved RoadSurat, Gujarat, 395004022 49564000investors.grievance@smt.inVisit Website